Teva has opted to settle the first trial among hundreds of cases that accuse it and other drugmakers of helping to fuel the opioid addiction epidemic in the US.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
